Genopole’s Citizens

Genopole governance

The Groupement d’intérêt public (GIP, a form of public-private partnership for missions of public interest) Genopole continues to serve thanks to the unfailing support of its 12 members, four of which are fund providers. The GIP has policy and scientific strategy bodies to guide the assurance of its missions.

The biocluster receives stable support from a number of public entities (French State, Île-de-France Regional Council, etc.) who contribute significant funding for investments in and the functioning of shared-use technological platforms and the teams serving Genopole’s labs and businesses.

GIP Genopole General Meeting

The General Meeting is composed of representatives designated by each member institution. The General Meeting administers and makes all decisions concerning the GIP:

adoption of the budget,
annual program.

It also deliberates nominations to the Committee for Science, Innovation and Industry (CSII) and elects the president and vice-president.

General Meeting members

Île-de-France Region

Stéphane Beaudet

President of Genopole

Ministère de l'Enseignement supérieur, de la Recherche et de l'Espace

Ministry of Higher Education, Research and Space

Member

Conseil départemental de l'Essonne
Essonne Terre d'Avenirs

Essonne, The department

Laure Darcos

Vice-president of the General Meeting

Grand Paris Sud

Stéphane Bodet

Member

Evry-Courcouronnes

Stéphane Beaudet

Member of Genopole

AFM-Telethon

Laurence Tiennot-Herment

Membre

University Evry Paris-Saclay

Vincent Bouhier

Member

CEA

Anne-Isabelle Etienvre

Member

CHSF

François Berard

Member

Inserm

Didier Samuel

Member

SEM Genopole

Member

Université Paris-Saclay - Membre de l'AG du GIP Genopole

University Paris-Saclay

Camille Galap

Member

Committee for Science and Innovation (CSI)

The CSI is composed of qualified persons with particular competencies in Genopole’s fields of activity. Its members are approved by the General Meeting. The role of the CSI is to provide the General Meeting with opinions and recommendations on the scientific and industrial orientations of GIP Genopole. A seat on the CSI is accorded intuiti personae and the members act in strict independence of their affiliations.

CSI President

Mehran Mostafavi,

Vice President for Research at Paris-Saclay University and former Deputy Scientific Director of CNRS Chemistry, has just been appointed chair of Genopole’s Scientific and Innovation Committee.

CSI Members

Florence Agostino-Etchetto, CEO – Lyonbiopole
Emmanuel Barillot, Team Leader – Institut Curie
Nadine Bongaerts-Duportet, Administrative Board Member – Hello Tomorrow
Fayza Daboussi, Director of Life Sciences – Toulouse White Biotechnology
Olivier Dugas, Deputy Technical Lead, Precision Farming – Limagrain
Marco Fiorini, General Manager, IA & Cancer Group – PariSanté Campus
Philippe Gesnouin, EIT Digital & EIT Health Project Officer – Inrae
Xavier Gidrol, Director of the Large Scale Biology laboratory and the Biomics laboratory – CEA
David Guerrand, Biotech Business Director – Lallemand
Christophe Junot, Research Director – CEA
Philippe Lavocat, Chief Executive Officer – GENCI
Franck Molina, Director of Public-Private Research Center – SyséDiag (CNRS-Alcediag)
Sylvie Ponchaut, Managing Director – BioWin
Eric Quemeneur, Executive Vice President and R&D Vice President – Transgene SA
Emmanuelle Quilès, Chief Executive Officer – Janssen France
Sébastien Ribault, Vice-President – Merck Life Sciences
Dominique Stoppa-Lyonnet, Professor of Genetics, Paris-Descartes University, and Head of Genetics – Institut Curie